» Articles » PMID: 22235228

IgG Placental Transfer in Healthy and Pathological Pregnancies

Overview
Date 2012 Jan 12
PMID 22235228
Citations 418
Authors
Affiliations
Soon will be listed here.
Abstract

Placental transfer of maternal IgG antibodies to the fetus is an important mechanism that provides protection to the infant while his/her humoral response is inefficient. IgG is the only antibody class that significantly crosses the human placenta. This crossing is mediated by FcRn expressed on syncytiotrophoblast cells. There is evidence that IgG transfer depends on the following: (i) maternal levels of total IgG and specific antibodies, (ii) gestational age, (iii) placental integrity, (iv) IgG subclass, and (v) nature of antigen, being more intense for thymus-dependent ones. These features represent the basis for maternal immunization strategies aimed at protecting newborns against neonatal and infantile infectious diseases. In some situations, such as mothers with primary immunodeficiencies, exogenous IgG acquired by intravenous immunoglobulin therapy crosses the placenta in similar patterns to endogenous immunoglobulins and may also protect the offspring from infections in early life. Inversely, harmful autoantibodies may cross the placenta and cause transitory autoimmune disease in the neonate.

Citing Articles

HIV-related Differences in Placental Immunology: Data From the PRACHITi Cohort in Pune, India.

Mathad J, Alexander M, Bhosale R, Naik S, Cranmer L, Kulkarni V Open Forum Infect Dis. 2025; 12(3):ofaf047.

PMID: 40046890 PMC: 11879550. DOI: 10.1093/ofid/ofaf047.


Clinical data and reporting quality in NMDAR-antibody encephalitis and pregnancy: a systematic review.

Harris S, Binks S, Skelly D, Fourie H, Cherrington-Walker P, Bajorek T BMJ Neurol Open. 2025; 7(1):e001005.

PMID: 40041614 PMC: 11877225. DOI: 10.1136/bmjno-2024-001005.


Impact of maternal COVID-19 infection on offspring immunity and maternal-fetal outcomes at different pregnancy stages: a cohort study.

Sun Y, Luo X, Chen N, Xie L, Hu S, Zhou M BMC Pregnancy Childbirth. 2025; 25(1):219.

PMID: 40022096 PMC: 11869480. DOI: 10.1186/s12884-025-07323-7.


SARS-CoV-2 Infection and Adverse Maternal and Perinatal Outcomes: Time-to-Event Analysis of a Hospital-Based Cohort Study of Pregnant Women in Rio de Janeiro, Brazil.

Brendolin M, Wakimoto M, Oliveira R, Mageste L, Nielsen-Saines K, Brasil P Viruses. 2025; 17(2).

PMID: 40006963 PMC: 11860397. DOI: 10.3390/v17020207.


Maternal F1 antibodies and cytokines in mother-neonate dog pairs in the plague focus.

Tang D, Bukai A, Qin S, Duan R, Lyu D, He Z Heliyon. 2025; 11(3):e42336.

PMID: 39991224 PMC: 11847103. DOI: 10.1016/j.heliyon.2025.e42336.


References
1.
Okoko B, Wesuperuma L, Ota M, Banya W, Pinder M, Gomez F . Influence of placental malaria infection and maternal hypergammaglobulinaemia on materno-foetal transfer of measles and tetanus antibodies in a rural west African population. J Health Popul Nutr. 2001; 19(2):59-65. View

2.
Palmeira P, Costa-Carvalho B, Arslanian C, Pontes G, Nagao A, Carneiro-Sampaio M . Transfer of antibodies across the placenta and in breast milk from mothers on intravenous immunoglobulin. Pediatr Allergy Immunol. 2009; 20(6):528-35. DOI: 10.1111/j.1399-3038.2008.00828.x. View

3.
Baker C, Rench M, McInnes P . Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine. Vaccine. 2003; 21(24):3468-72. DOI: 10.1016/s0264-410x(03)00353-0. View

4.
Tincani A, Rebaioli C, Andreoli L, Lojacono A, Motta M . Neonatal effects of maternal antiphospholipid syndrome. Curr Rheumatol Rep. 2009; 11(1):70-6. DOI: 10.1007/s11926-009-0010-8. View

5.
Yu Z, Lennon V . Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases. N Engl J Med. 1999; 340(3):227-8. DOI: 10.1056/NEJM199901213400311. View